Skip to content
MatchScript
Menu

Head-to-head · The Match Score

CoreAge Rx vs AM Rx

Both scored on the same six-factor Match Score. CoreAge Rx wins this matchup with a 91 to 42 edge.

Higher Match Score

CoreAge Rx

#1 · Grade A−

Anyone who wants transparent flat pricing, fast nationwide access, and no teaser-rate bait-and-switch.

Visit CoreAge Rx
VS

AM Rx

#495 · Grade C

Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

Visit AM Rx

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
82
49
Speed to Start
97
49
Formulary Match
80
66
Support Level
93
52
Flexibility
97
20
Transparency
95
20

Price, coverage & formulary

DetailCoreAge RxAM Rx
Semaglutide$149/mo$151/mo (quarterly plan, plus a separate fee, compounded)
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjectable onlyInjectable only
Match Score91 · A−42 · C
Winner: CoreAge Rx

CoreAge Rx is our #1-ranked provider overall, and it takes this matchup too — a 91 Match Score to AM Rx's 42. The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.

AM Rx is still a fair pick if its strengths line up with yours — best for: Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full CoreAge Rx reviewFull AM Rx review

More head-to-heads

Or browse alternatives to CoreAge Rx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.